ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

BDTX Black Diamond Therapeutics Inc

5.32
0.00 (0.00%)
Pre Market
Last Updated: 03:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Black Diamond Therapeutics Inc BDTX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 5.32 03:00:00
Open Price Low Price High Price Close Price Previous Close
5.32
more quote information »

Recent News

Date Time Source Heading
6/06/202416:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/06/202416:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/06/202415:06EDGAR2Form 8-K - Current report
6/01/202409:00GLOBEBlack Diamond Therapeutics Presents Promising BDTX-1535..
5/29/202407:00GLOBEBlack Diamond Therapeutics to Participate in Jefferies..
5/13/202418:09EDGAR2Form SC 13D/A - General statement of acquisition of..
5/09/202406:30GLOBEBlack Diamond Therapeutics Reports First Quarter 2024..
5/09/202406:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/09/202406:10EDGAR2Form 8-K - Current report
4/24/202415:05GLOBEBlack Diamond Therapeutics Announces Presentations at the..
4/11/202407:00GLOBEBlack Diamond Therapeutics Announces Changes to Board of..
4/07/202417:00GLOBEBlack Diamond Therapeutics Presents Novel Real-World..
4/03/202407:00GLOBEBlack Diamond Therapeutics to Participate in Upcoming..
3/12/202407:00GLOBEBlack Diamond Therapeutics Reports Fourth Quarter and Full..
3/11/202412:14EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
3/05/202415:30GLOBEBlack Diamond Therapeutics Announces Upcoming Presentation..
2/28/202407:00GLOBEBlack Diamond Therapeutics to Participate in the TD Cowen..
2/15/202416:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/15/202416:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/15/202416:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/15/202416:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/18/202415:04EDGAR2Form 8-K - Current report
1/04/202407:07EDGAR2Form 8-K - Current report
1/04/202407:00GLOBEBlack Diamond Therapeutics Announces Corporate Update and..
12/13/202306:08EDGAR2Form 8-K - Current report
12/13/202306:00GLOBEBlack Diamond Therapeutics Announces Topline Results from..
11/07/202307:00GLOBEBlack Diamond Therapeutics to Participate in Upcoming..
11/06/202306:45GLOBEBlack Diamond Therapeutics Reports Third Quarter 2023..
11/06/202306:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/06/202306:10EDGAR2Form 8-K - Current report
10/14/202311:30GLOBEBlack Diamond Therapeutics Presents Dose Escalation Data..
10/04/202311:14GLOBEBlack Diamond Therapeutics to Present Preclinical and..
9/18/202316:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/18/202306:12EDGAR2Form 8-K - Current report
9/18/202306:00GLOBEBlack Diamond Therapeutics Announces CEO Transition
9/11/202307:00GLOBEBlack Diamond Therapeutics Announces First Patients Dosed in..
9/05/202307:00GLOBEBlack Diamond Therapeutics to Participate in Upcoming..
8/11/202306:30GLOBEBlack Diamond Therapeutics Reports Second Quarter 2023..
8/11/202306:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/11/202306:22EDGAR2Form 8-K - Current report
6/30/202315:03EDGAR2Form 8-K - Current report
6/30/202315:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
6/29/202319:57GLOBEBlack Diamond Therapeutics Announces Pricing of Public..
6/29/202305:02EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
6/28/202315:23GLOBEBlack Diamond Therapeutics Announces Proposed Public..
6/27/202306:00GLOBEBlack Diamond Therapeutics Announces Initial Dose Escalation..